Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIkena Oncology Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q1 2027 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2027 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q3 2027 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2027 | 1 | -$0.29 | -$0.29 | -$0.29 |
Ikena Oncology Inc Earnings Date And Information
Ikena Oncology Inc last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.531 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.401. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Ikena Oncology Inc has generated $-1 earnings per share over the last year ($-1.02 diluted earnings per share) and currently has a price-to-earnings ratio of -1.27. Ikena Oncology Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Ikena Oncology Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | N/A | -$0.53 | N/A | $1.25 M | $0 |
| 07/24/2025 | Q2 2025 | -$0.14 | -$0.06 | 0.08 | $1.25 M | $0 |
| 05/08/2025 | Q1 2025 | -$0.21 | -$0.18 | 0.03 | N/A | $0 |
| 03/06/2025 | Q4 2024 | -$0.19 | -$0.19 | 0 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.27 | -$0.21 | 0.06 | $1.25 M | $0 |
| 08/08/2024 | Q2 2024 | -$0.31 | -$0.28 | 0.03 | $875.00 K | $0 |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.33 | 0.07 | N/A | $0 |
| 03/12/2024 | Q4 2023 | -$0.41 | -$0.41 | 0 | N/A | $659.00 K |
| 11/09/2023 | Q3 2023 | -$0.44 | -$0.40 | 0.04 | $2.84 M | $1.19 M |
| 08/10/2023 | Q2 2023 | -$0.48 | -$0.44 | 0.04 | $3.85 M | $2.00 M |
| 05/15/2023 | Q1 2023 | -$0.46 | -$0.39 | 0.07 | $4.61 M | $5.31 M |
| 03/14/2023 | Q4 2022 | -$0.53 | -$0.36 | 0.17 | $6.02 M | $5.45 M |
| 11/07/2022 | Q3 2022 | -$0.50 | -$0.46 | 0.04 | $4.32 M | $6.40 M |
| 08/11/2022 | Q2 2022 | -$0.48 | -$0.55 | -0.07 | $3.87 M | $382.00 K |
| 05/12/2022 | Q1 2022 | -$0.42 | -$0.46 | -0.04 | $4.57 M | $3.38 M |
| 03/17/2022 | Q4 2021 | -$0.51 | $0.08 | 0.59 | $4.79 M | $20.22 M |
| 11/10/2021 | Q3 2021 | -$0.41 | -$0.40 | 0.01 | $4.05 M | $3.75 M |
| 08/12/2021 | Q2 2021 | -$0.32 | -$0.35 | -0.03 | $3.93 M | $3.55 M |
| 05/13/2021 | Q1 2021 | -$0.68 | -$2.52 | -1.84 | $3.97 M | $3.47 M |
| 12/30/2020 | Q4 2020 | N/A | -$1.86 | N/A | N/A | $65.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ikena Oncology Inc Earnings: FAQ's
The conference call for Ikena Oncology Inc's latest earnings report can be listened to online.
The conference call transcript for Ikena Oncology Inc's latest earnings report can be read online.
Ikena Oncology Inc (:IKNA) has a recorded net income of $-49,234,000.Ikena Oncology Inc has generated $-1.02 earnings per share over the last four quarters.
Ikena Oncology Inc (:IKNA) has a price-to-earnings ratio of -1.27 and price/earnings-to-growth ratio is 0.